Overview
- Editors:
-
-
Esther Zoref-Shani
-
Tel-Aviv University, Tel-Aviv, Israel
-
Oded Sperling
-
Tel-Aviv University, Tel-Aviv, Israel
Rabin Medical Center, Petah-Tikva, Israel
Access this book
Other ways to access
Table of contents (76 chapters)
-
Purinergic Signalling
-
- Carlo Crifo, Elisabetta Capuozzo, Judit Ovadi, Costantino Salerno
Pages 197-200
-
- Asher Shainberg, Noam Safran, Nissim Balas, Tova Zinman, Ahuva Isaac, Keren Schwab et al.
Pages 201-205
-
- Donald Dassesse, Jean-Marie Vanderwinden, Ilan Golberg, Jean-Jacques Vanderhaeghen, Serge N. Schiffmann
Pages 207-216
-
- Ayelet Reshef, Oded Sperling, Esther Zoref-Shani
Pages 217-221
-
- S. Mariette Schrier, Ad P. Ijzerman, Gerard J. Mulder, J. Fred Nagelkerke
Pages 223-226
-
-
Inborn Errors of Pyrimidine Metabolism
-
- Albert H. Van Gennip, Andre B. P. Van Kuilenburg
Pages 233-241
-
- Andre B. P. Van Kuilenburg, Henk Van Lenthe, Gudrun Gohlich Ratmann, Birgit Assmann, George F. Hoffmann, Christa Brautigam et al.
Pages 243-245
-
- Andre B. P. Van Kuilenburg, Janet Haasjes, Rutger Meinsma, Hans R. Waterham, Peter Vrelem, Alebrt H. Van Gennip
Pages 247-250
-
- Andre B. P. Van Kuilenburg, Janet Haasjes, Henk Van Lenthe, Lida Zoetekouw, Hans R. Waterham, Peter Vreken et al.
Pages 251-255
-
- Andre B.P. van Kuilenburg, Rutger Meinsma, Peter Vreken, Hans R. Waterham, Albert H. van Gennip
Pages 257-261
-
Pyrimidine Metabolism
-
- Wolfgang Knecht, Birgitte Munch-Petersen, Jure Piskur
Pages 263-266
-
- Wolfgang Knecht, Monika Loffler
Pages 267-270
-
Oncology and Chemotherapy
-
- Ronney A. De Abreu, Lambert H.J. Lambooy, Kai Ahment, Connie Brouwer, Jenneke J. Keizer-Garritsen, Jos P.M. Bokkerink et al.
Pages 271-275
-
- Jorgen Bierau, Alberth H. Van Gennip, Andre B.P. Van Kuilenburg
Pages 277-280
-
- Tatjana Spasokoukotskaja, Zsolt Csapo, Maria Sasvari-Szekely, Szula Virga, Iannis Talianidis, Staffan Eriksson et al.
Pages 281-285
-
- Clasina L. van der Wilt, Judith R. Kroep, Andries M. Bergman, Willem J.P. Loves, Enrique Alvarez, Iannnis Talianidis et al.
Pages 287-290
-
- Godefridus J. Peters, Michiel de Bruin, Masakazu Fukushima, Baukelien van Triest, Klaas Hoekman, Herbert M. Pinedo et al.
Pages 291-294
-
- Bjørn Spilsberg, Frode Rise, Dirk Petersen, Jon Nissen-Meyer
Pages 295-301
-
- Harold H.J. Backus, Dirube Wouters, Clasina L. Van Der Wilt, Catherina M. Kuiper, Cees J. Van Groeningen, Herbert et al.
Pages 303-306
About this book
th This volume contains articles presented at the X International Symposium on Purines and Pyrimidines in Man, held on May 14 19, 2000 in Tel Aviv, Israel. The first symposium in this series took place in Tel Aviv in 1973. Since then, the symposium has been held every three years in different parts of the world, including Europe, USA and Japan. The participants, in this series of symposia, are characterised by a wide interest in the various aspects of purines and pyrimidines in man, which include biochemistry, genetics, pharmacology, physiology, clinics, etc. Presentations in the symposia include clarification of metabolic pathways, characterisation of enzyme structure and kinetics and discoveries of new inborn errors of metabolism and suggestions for new therapeutic approaches for these inborn errors. In addition, development of new purine and pyrimidine derivatives for the treatment of cancer and viral diseases, and many more subjects of mutual interest were brought to the fore. With the development of therapeutic means and of new research tools, we have witnessed changes in the areas of interest. The interest in gout and uric acid urolithiasis has lessened, whereas molecular aspects, the role of purine and pyrimidine substances in neurotransmission and in purinergic signaling appear to gain greater interest. The articles, included in this volume, contain new data pertaining to the various aspects detailed above.